News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biomet Inc. 1Q Sales Disappoint, Rising 2 Percent
October 13, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Forbes -- WARSAW, Ind. --Medical device maker Biomet Inc. said Wednesday its sales rose 2 percent in the first quarter, slower than the privately held company had expected.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
·
2 min read
·
Gabrielle Masson
Layoffs
Gilead wipes out most of Arcellx workforce
May 7, 2026
·
1 min read
·
Angela Gabriel
Earnings
Sarepta says to ‘exercise prudence’ in setting expectations for Elevidys’ recovery
May 7, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
May 6, 2026
·
2 min read
·
Nick Paul Taylor
